Prosecution Insights
Last updated: November 20, 2026

Philip Earl Stimpert, USPTO Patent Examiner

Listed by the USPTO as STIMPERT, PHILIP EARL

Tech Center 3700 • Art Units: 1723 3746 3783

This examiner grants 63% of resolved cases

Analysis

Stimpert, Philip Earl is assigned to Tech Center 3700 and Art Unit 1723. The profile contains 902 resolved cases and a 63.3% allowance rate. The median time to allowance is 1294 days. Interviews are associated with a 48.8% lift, a substantial signal in this record.

The leading companies are Boston Scientific Corporation, Becton, Dickinson and Company, and DEKA Products Limited Partnership. The listed firms are MARSHALL, GERSTEIN & BORUN LLP, Maschoff Brennan (OC)(BD), and SEAGER, TUFTE & WICKHEM, LLP. The allowance rate supports a realistic path to allowance, but the timing figure calls for early prosecution planning. The interview lift makes focused examiner engagement especially relevant when addressing claim scope or technical distinctions.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

63.3%
Allow Rate
-6.7% vs TC avg
970
Total Applications
+48.8%
Interview Lift
1294
Avg Prosecution Days
Based on 902 resolved cases, 2023–2026

Rejection Statute Breakdown

0.5%
§101 Eligibility
19.9%
§102 Novelty
49.3%
§103 Obviousness
28.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18631236 PUNCTURE NEEDLE, ULTRASOUND DIAGNOSTIC APPARATUS, AND CONTROL METHOD OF ULTRASOUND DIAGNOSTIC APPARATUS Final Rejection FUJIFILM Corporation
18119785 SELF CENTERING LOW FRICTION EXTENDABLE CATHETER Non-Final OA Imperative Care, Inc.
18451778 MEDICAL DEVICES HAVING CONTROLLABLY ACTUATED ANCHORING, FRICTION REDUCTION, AND DEVICE MOVEMENT Non-Final OA STRYKER EUROPEAN OPERATIONS LIMITED
17988192 INTRODUCER WITH SALINE ANTECHAMBER Final Rejection Boston Scientific Scimed, Inc.
17988114 DEVICES, SYSTEMS, AND METHODS FOR FLUID DELIVERY Non-Final OA Boston Scientific Scimed, Inc.
17859477 RADIALLY CLOCKED STEERABLE CATHETER Non-Final OA BOSTON SCIENTIFIC SCIMED, INC.
18154183 PUNCTURING DEVICE COMPRISING A DISTAL BALLOON FEATURE Final Rejection Boston Scientific Medical Device Limited
18775735 Catheter System Non-Final OA TERUMO KABUSHIKI KAISHA
18124520 INFUSION DEVICE HUB FOR INTELLIGENT OPERATION OF INFUSION ACCESSORIES Non-Final OA CareFusion 303, Inc.
18087753 PRESSURE DETECTION SYSTEM AND METHOD Non-Final OA CareFusion 303, Inc.
18019939 PRIME TUBE CONFIGURATIONS FOR SYRINGE Final Rejection Bayer HealthCare LLC
18091149 WOUND DEBRIDEMENT BY IRRIGATION WITH ULTRASONICALLY ACTIVATED MICROBUBBLES Final Rejection Solventum Intellectual Properties Company
18112455 MEDICAL BALLOON SENSING ASSEMBLY AND METHOD Final Rejection EDWARDS LIFESCIENCES CORPORATION
18450081 ADHESIVE LAYER WITH MULTIPLE STRENGTHS OF ADHESIVES FOR SECURING AN ON-BODY MEDICAL DEVICE TO A USER Final Rejection INSULET CORPORATION
18665770 SYSTEM, METHOD, AND APPARATUS FOR INFUSING FLUID Non-Final OA DEKA Products Limited Partnership
18087058 Delivery Device Apparatuses, Systems, and Methods Non-Final OA DEKA Products Limited Partnership
17871345 SYSTEMS AND METHODS FOR FLUID DELIVERY Non-Final OA DEKA Products Limited Partnership
18866898 Catheter Placement System and Method Non-Final OA C. R. Bard, Inc.
18283626 DUAL PIEZOELECTRIC STACK PLUNGER SUB-ASSEMBLY Final Rejection BECTON, DICKINSON AND COMPANY
18272788 OCCULUSION SENSOR FOR PUMP ASSEMBLY Non-Final OA Becton, Dickinson and Company
18092583 Vascular Access System with Secondary Catheter Non-Final OA Becton, Dickinson and Company
18201645 FILTER FOR INFUSION PUMP SYSTEMS Non-Final OA Tandem Diabetes Care, Inc.
18273707 Electronic System for a Drug Delivery Device and Drug Delivery Device Non-Final OA Sanofi
17920068 INFUSION BOX OF INFUSION APPARATUS, INFUSION APPARATUS, AND INFUSION PUMP Non-Final OA CHANGSHA MAGILL MEDICAL TECHNOLOGY CO., LTD.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Philip Earl Stimpert's allowance rate?

63.3% of resolved applications examined by Philip Earl Stimpert were allowed (902 resolved cases), compared with 60.2% across Art Unit 1723 over the last five years.

Does an interview help with examiner Philip Earl Stimpert?

This examiner's interview lift is +48.8 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Philip Earl Stimpert take to allow a patent?

Applications allowed by Philip Earl Stimpert took 1,294 days on average from filing to allowance.

Which art unit does examiner Philip Earl Stimpert work in?

Philip Earl Stimpert examines applications in Art Unit 1723 in Tech Center 3700 (Medical Devices & Mechanical Engineering).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month